Virtuix is no longer just a niche gadget for VR gamers—it’s pushing its full-body movement tech into military training, where multiple U.S. service branches are already testing it. The real question is whether this shift, plus faster ways to turn real-world footage into walkable virtual environments, can turn early pilots into steady demand—or whether funding needs and slow defense rollouts get in the way.Read more

Cue Biopharma bets its future on a new allergy drug designed by the same scientist who created Xolair, aiming to make treatment far less frequent for people with chronic hives and other allergic conditions. A key mid-stage trial result is coming soon, and it could either put Cue on big pharma’s radar or expose just how risky this turnaround really is.Read more